In Vitro Technologies has been announced as the distributor for Novus Biologicals in Australia and New Zealand as of 1 July 2015. [ + ]

The laboratory information system interface BloodNet dominated the competition in this year's iAwards for the ACT — an annual event which honours companies at the cutting edge of technology innovation. [ + ]

CSIRO has welcomed the reappointment of Shirley In't Veld and the appointment of Brian Watson to its board. [ + ]

A naturally occurring modified DNA base appears to be stably incorporated in the DNA of many mammalian tissues, possibly representing an expansion of the functional DNA alphabet. [ + ]

Scientists have created an ultrathin membrane with nanoscale crumples, providing an increased surface area for filtering substances that remains strong and does not buckle — even under extreme pressures. [ + ]

North American hospitals now have the opportunity to acquire Indigo-Clean — a light fixture that uses Continuous Environmental Disinfection technology to continuously kill harmful bacteria linked to hospital-acquired infections (HAIs). [ + ]

Questacon has strengthened its relationship with the Singapore Science Centre following a memorandum of understanding (MoU) that will build the capacity of each centre and have flow-on benefits to the region.

Genea Biocells has announced the expansion of its operations to the United States, in a move described by general manager Dr Uli Schmidt as "the next step to grow Genea Biocells into a world-leading stem cell company". [ + ]

The annual FIRST world championship challenged students from around the world to brainstorm, design, prototype, build and program a robot in just 45 days. [ + ]

Microscope manufacturer WITec's Raman imaging system, apyron, was awarded first prize at the Achema 2015 Innovation Awards in the category of Laboratory and Analytical Technologies. [ + ]

Nominations are now open for the 2015 CSL Florey Medal, awarded biennially to an Australian researcher who has made a significant lifetime achievement in biomedical science and/or human health advancement. [ + ]

Researchers have recently demonstrated the principle of real-time ligand binding to G protein-coupled receptors (GPCRs), the single most important family of drug targets, using bioluminescence resonance energy transfer (BRET). [ + ]

Hitachi High-Technologies and QIAGEN have entered into a long-term strategic collaboration involving initiatives to deliver advances in molecular testing. [ + ]

Living Cell Technologies last week announced positive results from its Phase I/IIa clinical study of NTCELL, an experimental regenerative cell therapy being studied as a disease-modifying agent in Parkinson's disease. [ + ]

Research Facilities Design and Development (RFDD), held last month at the Aerial UTS Function Centre in Ultimo, was a meeting of the minds to discuss research spaces of the future. [ + ]